Siegrist, D.; Jonsdottir, H.R.; Bouveret, M.; Boda, B.; Constant, S.; Engler, O.B.
Multidrug Combinations against SARS-CoV-2 Using GS-441524 or Ivermectin with Molnupiravir and/or Nirmatrelvir in Reconstituted Human Nasal Airway Epithelia. Pharmaceutics 2024, 16, 1262.
https://doi.org/10.3390/pharmaceutics16101262
AMA Style
Siegrist D, Jonsdottir HR, Bouveret M, Boda B, Constant S, Engler OB.
Multidrug Combinations against SARS-CoV-2 Using GS-441524 or Ivermectin with Molnupiravir and/or Nirmatrelvir in Reconstituted Human Nasal Airway Epithelia. Pharmaceutics. 2024; 16(10):1262.
https://doi.org/10.3390/pharmaceutics16101262
Chicago/Turabian Style
Siegrist, Denise, Hulda R. Jonsdottir, Mendy Bouveret, Bernadett Boda, Samuel Constant, and Olivier B. Engler.
2024. "Multidrug Combinations against SARS-CoV-2 Using GS-441524 or Ivermectin with Molnupiravir and/or Nirmatrelvir in Reconstituted Human Nasal Airway Epithelia" Pharmaceutics 16, no. 10: 1262.
https://doi.org/10.3390/pharmaceutics16101262
APA Style
Siegrist, D., Jonsdottir, H. R., Bouveret, M., Boda, B., Constant, S., & Engler, O. B.
(2024). Multidrug Combinations against SARS-CoV-2 Using GS-441524 or Ivermectin with Molnupiravir and/or Nirmatrelvir in Reconstituted Human Nasal Airway Epithelia. Pharmaceutics, 16(10), 1262.
https://doi.org/10.3390/pharmaceutics16101262